Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-31 @ 11:42 AM
Study NCT ID:
NCT07318818
Status:
RECRUITING
Last Update Posted:
2026-02-18
First Post:
2025-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Trial of P134 Cells in Recurrent Glioblastoma
Sponsor:
Tasly Pharmaceutical Group Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01-05
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-27
First Submit QC Date:
None
Study First Post Date:
2026-01-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-13
Last Update Post Date:
2026-02-18
Last Update Post Date Type:
ACTUAL